Research & Development

超碰视频在线观看超碰97zyz资源总站百度超碰97 总站 中文字幕坚持“房住不炒” 银保监会严查房地产信托!

發布時間︰

  霍去病探手朝城下看看,只見羌人的尸體在城下堆積如山,並且從城下一直延伸到百丈以外,遂搖搖頭道︰“沒希望了,還是殺掉來的干淨些。”   “誰能預料會出這種事,不過呢,能逼迫渾邪王跟我們打一場攻城戰,我覺得是一件好事!”超碰视频在线观看   “給我一匹馬!”超碰97zyz资源总站百度   劉徹看了阿嬌好久,長長的出了一口氣道︰“一百里可成?”超碰97 总站 中文字幕   雲瑯就對那個婦人道︰“你丈夫?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo